Picture of NANOSONICS logo

NAN — NANOSONICS News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Australia's Nanosonics gains on FDA's De Novo clearance for CORIS system

** Shares of Australia's Nanosonics NAN.AX rise 13.3% to A$4.95; their highest since August 14, 2023

** NAN says the U.S. Food and Drug Administration has granted De Novo clearance for its latest innovation, the CORIS system

** CORIS is an advanced cleaning system engineered to address one of the most critical challenges in medical device reprocessing: the effective cleaning of flexible endoscopes

** Stock up 61.5% YTD

 (Reporting by Rishav Chatterjee in Bengaluru)

 ((Rishav.Chatterjee@thomsonreuters.com;))

Recent news on NANOSONICS

See all news